ICD-11 code : 6D71;
Preferred Label : Mild neurocognitive disorder;
ICD-11 definition : Mild neurocognitive disorder is characterized by the subjective experience of a decline
from a previous level of cognitive functioning, accompanied by objective evidence
of impairment in performance on one or more cognitive domains relative to that expected
given the individual's age and general level of intellectual functioning that is not
sufficiently severe to significantly interfere with independence in the person's performance
of activities of daily living. The cognitive impairment is not entirely attributable
to normal aging. The cognitive impairment may be attributable to an underlying disease
of the nervous system, a trauma, an infection or other disease process affecting specific
areas of the brain, or to chronic use of specific substances or medications, or the
etiology may be undetermined.;
ICD-11 inclusion : mild lack of memory following organic brain damage; mild memory loss following organic brain damage; mild memory disturbance following organic brain damage; minor neurocognitive disorder; mild memory disorder following organic brain damage; mild cognitive impairment;
Origin ID : 195531803;
UMLS CUI : C0338656;
Automatic exact mappings (from CISMeF team)
- Currated CISMeF NLP mapping
- Semantic type(s)
- UMLS correspondences (same concept)
Mild neurocognitive disorder is characterized by the subjective experience of a decline
from a previous level of cognitive functioning, accompanied by objective evidence
of impairment in performance on one or more cognitive domains relative to that expected
given the individual's age and general level of intellectual functioning that is not
sufficiently severe to significantly interfere with independence in the person's performance
of activities of daily living. The cognitive impairment is not entirely attributable
to normal aging. The cognitive impairment may be attributable to an underlying disease
of the nervous system, a trauma, an infection or other disease process affecting specific
areas of the brain, or to chronic use of specific substances or medications, or the
etiology may be undetermined.
